designate the following steps in gene therapy: “first, the partial removal of a patients cells, second, the introduction of normal, functional copies of the gene via vectors to replace defective cells in the patient, and finally, the reintroduction of the modified cells into the patient once the genes have been fixed in their vectors” (Bergeson). Treatment of diseases at the genetic level is a rather tempting prospect. Nevertheless, similar to any intervention in the human body, it can lead to completely unexpected results. Over half a century of development of this field of medicine scientists have received both positive and negative experience in the use of gene therapy. For this reason, currently, the question of whether the further development and use of gene therapy should be allowed is particularly important in modern science. However, despite the various ethical objections to genetic engineering, this paper defends the idea of further development of this field, since the use of gene therapy is able to save a large number of human lives, as well as prevent the development of serious and dangerous diseases, which are rather difficult or even impossible to treat.
As mentioned above, humanity suffers from a variety of serious diseases. Moreover, some of them have a hereditary nature that implies that they can pass from parents to their children. The problem is that many of these diseases are resistant to treatment. This means that people who suffer from them are doomed to a painful life. Unlike other healthy people who enjoy life, these people are regular patients of hospitals and clinics, and their lives are always subject to continuous risk. In this regard, gene therapy is seen as a revolution in modern science, which is able to save mankind from a variety of serious and even untreatable diseases that are transmitted by heredity. Historically, gene therapy was aimed at the treatment of hereditary genetic diseases, but later it has expanded its field of